Bone Drug's inner workings revealed in new study
NCT ID NCT05688969
First seen Jan 03, 2026 · Last updated May 24, 2026 · Updated 31 times
Summary
This study aims to understand how the osteoporosis drug romosozumab changes bone cells over time. Researchers will study 16 postmenopausal women who are already prescribed this medication. The goal is to see if the drug increases early bone-forming cells but not later ones, helping explain how it strengthens bones.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOPOROSIS, POSTMENOPAUSAL are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Mass General Brigham
RECRUITINGBoston, Massachusetts, 02114, United States
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.